Natural Product: NPC543360

Natural Product IDNPC543360
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
7-hydroxy-6,8-dimethoxy-2-(4-methoxyphenyl)-5-[(2~{S},3~{R},4~{S},5~{S},6~{S})-3,4,5-trihydroxy-6-[[(2~{R},3~{R},4~{S},5~{S},6~{R})-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromen-4-one
IUPAC Name 7-hydroxy-6,8-dimethoxy-2-(4-methoxyphenyl)-5-[(2~{S},3~{R},4~{S},5~{S},6~{S})-3,4,5-trihydroxy-6-[[(2~{R},3~{R},4~{S},5~{S},6~{R})-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromen-4-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey PDOZWYOOYIYRHV-MQZHJVRCSA-N
Standard InCHI InChI=1S/C30H36O17/c1-40-12-6-4-11(5-7-12)14-8-13(32)17-25(44-14)27(41-2)24(39)28(42-3)26(17)47-30-23(38)21(36)19(34)16(46-30)10-43-29-22(37)20(35)18(33)15(9-31)45-29/h4-8,15-16,18-23,29-31,33-39H,9-10H2,1-3H3/t15-,16+,18-,19-,20+,21+,22-,23-,29-,30+/m1/s1
SMILES COC1=CC=C(C2=CC(=O)C3=C(O[C@@H]4O[C@@H](CO[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)C(OC)=C(O)C(OC)=C3O2)C=C1

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   668.2 Volume:   612.996
?
Van der Waals volume.
Dense:   1.09 LogP:   0.506
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.231
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.232
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   10.0 Rigid Bonds:   30.0
TPSA:   256.66
?
Topological Polar Surface Area.
H-Bond Acceptor:   17.0
H-Bond Donor:   8.0 Rings:   5.0
Heavy Atoms:   17.0

MedChem Properties

QED Drug-Likeness Score:   0.118 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.814 Fsp3:   0.5
MCE-18:   120.556
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   1 PAINS Alert:   0
Colloidal aggregators:   0.54 Fluc inhibitor:   0.242
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.728
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.599
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.038 Promiscuous compounds:   0.222

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.268 MDCK Permeability:   -5.361
Pgp-inhibitor:   0.0 Pgp-substrate:   0.62
PAMPA:   0.995
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.736
20% Bioavailability (F20%):   0.136 30% Bioavailability (F30%):   0.879
50% Bioavailability (F50%):   0.986

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.002 MRP1:   0.185
Plasma Protein Binding (PPB):   84.109% Volume Distribution (VD):   -0.24
Fu: 15.882%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.308
BSEP inhibitor:   0.009

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.001
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.003
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.002
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.253
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  1.725 Half-life (T1/2):  3.735

ADMET: Toxicity

hERG Blockers:  0.024 hERG Blockers (10um):  0.081
Human Hepatotoxicity (H-HT):  0.676 Drug-induced Liver Injury (DILI):  0.988
AMES Toxicity:  0.913 Rat Oral Acute Toxicity:  0.007
Maximum Recommended Daily Dose:  0.013 Skin Sensitization:  0.998
Carcinogencity:  0.216 Eye Corrosion:  0.0
Eye Irritation:  0.019 Respiratory Toxicity:  0.004
Drug-induced Neurotoxicity:  0.007 Ototoxicity:  0.97
Hematotoxicity:  0.341 Drug-induced Nephrotoxicity:  0.713
Genotoxicity:  0.303 RPMI-8226 Immunitoxicity:  0.152
A549 Cytotoxicity:  0.339 Hek293 Cytotoxicity:  0.323
BCF:   0.28
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.056
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.729
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.786
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26817 Lysionotus pauciflorus Species Gesneriaceae Eukaryota n.a. n.a. n.a. PMID[21775221]
NPO26817 Lysionotus pauciflorus Species Gesneriaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO26817 Lysionotus pauciflorus Species Gesneriaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO26817 Lysionotus pauciflorus Species Gesneriaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO26817 Lysionotus pauciflorus Species Gesneriaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC543360 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.6146 Remote Similarity NPC204693
0.6042 Remote Similarity NPC22062
0.6042 Remote Similarity NPC473634
0.6042 Remote Similarity NPC138811
0.6 Remote Similarity NPC295613
0.6 Remote Similarity NPC473657
0.596 Remote Similarity NPC483707
0.5743 Remote Similarity NPC488089
0.5652 Remote Similarity NPC186807
0.5644 Remote Similarity NPC473623
0.5625 Remote Similarity NPC211594
0.5604 Remote Similarity NPC58053
0.5556 Remote Similarity NPC473512
0.5556 Remote Similarity NPC129827
0.5543 Remote Similarity NPC95090
0.5543 Remote Similarity NPC27408
0.5446 Remote Similarity NPC475366
0.5413 Remote Similarity NPC311850
0.5364 Remote Similarity NPC488083
0.534 Remote Similarity NPC209296
0.5294 Remote Similarity NPC488073
0.5294 Remote Similarity NPC284277
0.5294 Remote Similarity NPC475497
0.5283 Remote Similarity NPC135358
0.5268 Remote Similarity NPC68592
0.5248 Remote Similarity NPC102028
0.5238 Remote Similarity NPC189589
0.5234 Remote Similarity NPC244875
0.5213 Remote Similarity NPC259152
0.5204 Remote Similarity NPC61791
0.5176 Remote Similarity NPC208769
0.5158 Remote Similarity NPC610763
0.5149 Remote Similarity NPC44931
0.5149 Remote Similarity NPC275454
0.5146 Remote Similarity NPC46202
0.5128 Remote Similarity NPC262222
0.5106 Remote Similarity NPC143851
0.505 Remote Similarity NPC187379
0.505 Remote Similarity NPC603300
0.5047 Remote Similarity NPC287889

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC543360 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5472 Remote Similarity NPD7472 Pre-clinical
0.534 Remote Similarity NPD7054 Phase 4

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data